Align Technology (NASDAQ:ALGN) Q4 results:
Revenues: $649.8M (+21.7%); Clear Aligner sales: $543.6M (+22.0%); Scanner & Services: $106.2M (+20.1%).
Invisalign case shipments: 413.7K (+23.9%).
Net income: $121.3M (+24.5%); EPS: $1.53 (+27.5%).
Cash flow ops (full year): $747.3M (+34.7%).
Q1 guidance: Revenues: $615.0M –
630.0M (includes the impact in China cited below). Invisalign case
shipments: 396K – 406K; EPS: $18.65 – 18.74; non-GAAP EPS: $1.19 – 1.28.
Reduction of 20K – 25K Invisalign case shipments
and $30M – 35M less Invisalign and iTero revenue in China due to
coronavirus outbreak. Gross margin will be negatively impacted by 0.5%
due to the absorption of $3.0M – 4.0M in idle plant capacity costs in
China.
https://seekingalpha.com/news/3536012-align-tech-down-9-despite-q4-beat-coronavirus-creates-headwinds-in-china
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.